Conversely, pre-existing immunity to OVs via the formation of immune complexes could trigger MHC-II presentation leading to tumor colonization of pre-existing cytotoxic T cells (i.e., CD8+ T cells, CD4+ T cells, etc.), amplifying their antitumor activity (135, 136). This evidence concerns the gene CD8A and neoplasm.